Not to forget for mondyinvest—Clarity’s ligand alone is also very valuable, & took many years to develop through the past decade.
Also in no way is CU6 a single diagnostic or treatment & reliant on one trial or outcome .
True real value already well and truly held now .
(Opthea knocked back multiple partnership offers , which could have lead to a better trial design/ endpoints ,as understand it.
I never followed the company or story at all, did not get into it.
The funding terms however I find to have been completely shocking. To me the former CEO and board should not have been applauded for their deal wrt funding & raising money for the company- the absolute risk was a travesty, Was completely unacceptable risk. )
- Forums
- ASX - By Stock
- CU6 - General discussion
CU6
clarity pharmaceuticals ltd
Add to My Watchlist
1.84%
!
$3.73

Not to forget for mondyinvest—Clarity’s ligand alone is also...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.73 |
Change
-0.070(1.84%) |
Mkt cap ! $1.387B |
Open | High | Low | Value | Volume |
$3.82 | $3.99 | $3.64 | $16.80M | 4.475M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 65142 | $3.68 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.75 | 485 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 65142 | 3.680 |
2 | 2856 | 3.670 |
2 | 3300 | 3.650 |
1 | 1000 | 3.640 |
3 | 9005 | 3.610 |
Price($) | Vol. | No. |
---|---|---|
3.750 | 485 | 1 |
3.760 | 5420 | 2 |
3.790 | 11331 | 2 |
3.800 | 1344 | 1 |
3.820 | 12000 | 1 |
Last trade - 16.10pm 11/08/2025 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
WIN
WIN METALS LTD
Steve Norregard, CEO & MD
Steve Norregard
CEO & MD
SPONSORED BY The Market Online